Poor asthma control among US workers: Health-related quality of life, work impairment, and health care use

Journal of Occupational and Environmental Medicine

Volumn 56, Issue 4, 2014, Pages 425-430

  Vietri, Jeffrey ^a   Burslem, Kate ^b   Su, Jun ^b  

^a KANTAR HEALTH   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRODUCTIVITY; QUALITY OF LIFE; WORK DISABILITY; ABSENTEEISM; COMORBIDITY; DAILY LIFE ACTIVITY; EMPLOYMENT; EPIDEMIOLOGY; HEALTH SERVICE; HOSPITALIZATION; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ABSENTEEISM; ACTIVITIES OF DAILY LIVING; ADULT; ASTHMA; COMORBIDITY; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH SERVICES; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; MALE; QUALITY OF LIFE; UNITED STATES;

EID: 84898596366     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000123     Document Type: Article

References (44)

1. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus H. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood). 2001;20:233-241.
2. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156(3 Pt 1):787-793.
3. Akinbami LJ, Schoendorf KC. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief. 2012;94:1-8.
4. Colice GL. Categorizing asthma severity: an overview of national guidelines. Clin Med Res. 2004;2:155-163.
5. Siroux V, Pin I, Pison C, Kauffmann F. Severe asthma in the general population: definition and prevalence. Rev Mal Respir. 2004;21(5 Pt 1):961-969.
6. Moore WC, Bleeker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405-413.
7. Antonicelli L, Bucca C, Neri M, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23:723-729.
8. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J. 2002;19: 61-67.
9. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011;127:145-152.
10. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
11. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J. 1996;9:636-642.
12. National Asthma Education and Prevention Program. Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 2007.
13. American Lung Association Epidemiology and Statistics Unit, National Health Interview Survey 2004. Trends in Asthma Morbidity and Mortality 2005, American Lung Association. Washington, DC: Epidemiology & Statistics Unit; 2005.
14. Colice GL, Ostrom NK, Geller DE, et al. The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Ann Allergy Asthma Immunol. 2012;108:157-162.
15. Barros LL, Souza-Machado A, Correa LB, et al. Obesity and poor asthma control in patients with severe asthma. J Asthma. 2011;48:171-176.
16. Ohar JA. Asthma treatment guidelines: current recommendations, future goals. P&T Digest. 2005;2:23-27.
17. Long AA. The burden of asthma and improving patient outcomes. Am J Manag Care. 2011;17(suppl 3):S75-S81.
18. Cantrell CR, Priest JL, Cook CL, Fincham J, Burch SP. Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population. Popul Health Manag. 2011;14:33-41.
19. Strine TW, Mokdad A, Balluz LS, Berry JT, Gonzalez O. Impact of depression and anxiety on quality of life, health behaviors, and asthma control among adults in the United States with asthma, 2006. J Asthma. 2008;45:123-133.
20. Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med. 2001;95:37-39.
21. Vollmer WM, Markson LE, O'Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1647-1652.
22. Guilbert TW, Garris C, Jhingran P, et al. Asthma that is not well-controlled is associated with increased healthcare utilization and decreased quality of life. J Asthma. 2011;48:126-132.
23. Accordini S, Bugiana M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141:189-198.
24. Van Ganse E, Laforest L, Pietri G, et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J. 2002;20:260-267.
25. Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps BE. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62:126-133.
26. Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009;51:780-785.
27. Dean BB, Calimlim BM, Kindermann SL, Khandker RK, Tinkelman D. The impact of uncontrolled asthma on absenteeism and health-related quality of life. J Asthma. 2009;46:861-866.
28. Chen H, Gould MK, Blanc PD, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120:396-402.
29. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2010. Vital Health Stat 10. 2011;2011:1-80.
30. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10. 2012:252:1-207.
31. Thorn F, Celius H, Odegard T, Mandla R, Hexeberg E. Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway. Clin Mol Allergy. 2011;9:5.
32. Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res. 2009;18:415-422.
33. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549-556.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
35. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B, Keller SD. How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: QualityMetric Incorporated; 2002.
36. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.
37. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.
38. Norman GR, Sloan JA, Wyrwich KW. The truly remarkable universality of half a standard deviation: confirmation through another look. Expert Rev Pharmacoecon Outcomes Res. 2004;4:581-585.
39. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4.
40. Nguyen K, Zahran H, Iqbal S, Peng J, Boulay E. Factors associated with asthma control among adults in five New England states, 2006-2007. J Asthma. 2011;48:581-588.
41. Morris S. The impact of obesity on employment. Labour Econ. 2007;14:413-433.
42. Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS). J Asthma. 2010;47:257-262.
43. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119: 1454-1461.
44. Urbano FL. Review of the NAEPP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and Treatment Guidelines. J Manag Care Pharm. 2008;14:41.